ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QNV for the last quarter is 183.83 k CHF, and it's 44.16% lower compared to the previous quarter. The net income of Q4 23 is -2.86 M CHF.